Jeffrey M. Jonas, See Remarks at Sage Therapeutics, Inc. (SAGE), bought 20,226 shares at $49.56 ($20K) on 2015-12-31, disclosed to the SEC on 2016-01-07.
Open-market purchase of $20k SAGE by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.56 | 226 | $11K | 55.4% |
| 2 | $0.45 | 20,000 | $9K | 44.6% |
| Total | $1.00 avg | 20,226 | $20K | 100% |
| Filing → |
| KRTX | SELL | 2023-07-05 | $6.0M | — | Filing → |
| SAGE | SELL | 2023-02-10 | $1.0M | — | Filing → |
| SAGE | BUY | 2019-12-10 | $482K | — | Filing → |